Beau's Lines: Labs, Causes, and Next Steps

What Are Beau's Lines and Why Do They Form?

Beau's lines are transverse (horizontal) depressions or grooves that run across the width of the nail plate. They develop when the nail matrix, the tissue beneath the proximal nail fold responsible for producing new nail cells, temporarily stops or slows proliferation. The groove represents a period during which no nail plate was generated.

French physician Joseph Honoré Simon Beau first characterized these lines in 1846, connecting them to systemic illness [1]. The observation remains clinically relevant almost two centuries later because the nail plate acts as a biological diary. Fingernails grow at roughly 3.0 mm per month, while toenails grow at about 1.0 mm per month [2]. By measuring the distance from the proximal nail fold to the groove, a clinician can estimate how many weeks or months ago the insult occurred. A groove located 9 mm from the cuticle on a fingernail, for example, points to an event approximately three months prior.

The depth and width of the groove correlate with the severity and duration of the growth interruption [3]. A brief high fever may produce a shallow, narrow line. Prolonged chemotherapy can cause deep, wide grooves across every nail. When Beau's lines appear on all 20 nails simultaneously, the cause is almost certainly systemic. When only one nail is affected, local trauma or infection is the more likely explanation.

Common Causes of Beau's Lines

Beau's lines have a broad differential, but the causes cluster into four categories: systemic illness, nutritional deficiency, medication effects, and local trauma. Identifying which category applies determines the lab workup and treatment plan.

Systemic illness is the most frequently reported trigger. Severe febrile episodes, including pneumonia, scarlet fever, and COVID-19, can arrest nail matrix activity for days to weeks. A 2021 observational study of 1,009 COVID-19 survivors found that 3.7% developed Beau's lines within two to three months of acute infection [4]. Uncontrolled diabetes mellitus, peripheral vascular disease, and Raynaud's phenomenon also reduce blood flow to the nail matrix sufficiently to cause growth arrest [5]. Kawasaki disease in children is a classic association; Beau's lines appear in up to 50% of affected children during convalescence [6].

Nutritional deficiency accounts for a smaller but clinically important subset. Zinc deficiency is the best-documented nutritional cause. The American Academy of Dermatology notes that zinc is required for normal keratinocyte proliferation, and serum zinc levels below 60 mcg/dL have been associated with nail dystrophy including Beau's lines [7]. Iron deficiency anemia, severe protein malnutrition, and biotin deficiency are additional recognized triggers [8].

Medications, particularly cytotoxic chemotherapy agents (doxorubicin, cyclophosphamide, taxanes), retinoids, and anticonvulsants such as carbamazepine, can produce Beau's lines through direct suppression of matrix cell division [9].

Local trauma rounds out the list. Crush injuries, aggressive manicures, and chronic nail biting can damage the matrix of a single digit. These cases do not require systemic workup.

How Beau's Lines Are Diagnosed

Diagnosis begins with visual inspection and a thorough clinical history. No imaging or biopsy is needed in the vast majority of cases. The nail findings themselves are unmistakable once you know what to look for.

A clinician examines all 20 nails and records which are affected, the groove depth, and the estimated distance from the proximal nail fold. Dr. Antonella Tosti, Professor of Dermatology at the University of Miami and a leading authority on nail disorders, has written: "The single most important diagnostic step is determining whether Beau's lines are present on one nail or many. Multi-nail involvement mandates a systemic evaluation" [10]. This distribution pattern is the clinical fork in the road.

The history targets timing. The clinician works backward from the groove's position to pinpoint the approximate date of the insult, then asks: Were you hospitalized? Did you have a high fever? Did you start a new medication? Were you on a restrictive diet? Have you had surgery under general anesthesia? Each answer narrows the differential.

Dermoscopy (examination with a polarized-light dermatoscope) can help differentiate Beau's lines from other transverse nail abnormalities such as Muehrcke's lines (which are in the nail bed, not the plate) and true nail plate ridging from lichen planus or psoriasis [11]. Under dermoscopy, Beau's lines appear as a well-defined transverse trough with a smooth floor, while psoriatic nail pitting shows irregular, scattered depressions.

The Lab Panel Your Clinician Should Order

When Beau's lines appear on multiple nails and no obvious cause (recent surgery, documented febrile illness, chemotherapy) explains them, a targeted lab workup identifies the underlying trigger in most patients. There is no single consensus panel, but the American Academy of Dermatology and the British Association of Dermatologists both recommend starting with a focused screen rather than ordering exhaustive testing [7] [12].

Tier 1 (order on every unexplained multi-nail case):

• Complete blood count (CBC) with differential. Screens for anemia, infection, and hematologic malignancy.
• Comprehensive metabolic panel (CMP). Evaluates kidney function (BUN, creatinine), liver enzymes, glucose, calcium, and albumin. Low albumin (<3.5 g/dL) signals protein malnutrition or chronic illness.
• Serum zinc. Levels below 60 mcg/dL warrant supplementation. The Endocrine Society recommends measuring zinc in any patient with unexplained nail or hair changes [13].
• Thyroid-stimulating hormone (TSH). Both hypothyroidism and hyperthyroidism impair nail growth. A TSH outside the 0.4 to 4.0 mIU/L reference range triggers further thyroid evaluation [14].
• Ferritin and serum iron with total iron-binding capacity (TIBC). Ferritin below 30 ng/mL is consistent with iron deficiency even without frank anemia [15].

Tier 2 (order when Tier 1 is unrevealing or clinical suspicion is specific):

• Hemoglobin A1c. If fasting glucose is borderline or the patient has risk factors for diabetes.
• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). If vasculitis or connective tissue disease is suspected.
• Serum protein electrophoresis. If multiple myeloma or amyloidosis is a concern, particularly in older adults with unexplained Beau's lines plus fatigue and bone pain.
• Vitamin D (25-hydroxyvitamin D). Levels below 20 ng/mL are deficient. Evidence linking vitamin D deficiency directly to Beau's lines is limited, but it frequently coexists with zinc and iron deficiency [16].
• Antinuclear antibody (ANA). Only if Raynaud's phenomenon, skin changes, or joint symptoms suggest lupus or scleroderma.

Dr. Richard Scher, former Professor of Dermatology at Weill Cornell Medical College, has stated: "A methodical, two-tiered lab approach prevents both the under-investigation that misses treatable deficiency and the over-investigation that drives unnecessary cost and patient anxiety" [17].

Treatment: Correcting the Underlying Cause

There is no topical treatment, supplement, or procedure that directly repairs a Beau's line already present in the nail plate. The groove is a scar of past matrix arrest, and it will grow out on its own. Fingernail lines resolve in approximately four to six months. Toenail lines take 12 to 18 months [2]. Treatment targets the cause so that new, healthy nail plate grows in behind the groove.

For zinc deficiency, the standard replacement dose is 220 mg of zinc sulfate (containing 50 mg elemental zinc) once daily for 8 to 12 weeks, followed by a recheck of serum zinc [7]. Taking zinc with food reduces nausea. Copper depletion is a risk with prolonged supplementation exceeding three months, so a copper level should be checked if therapy continues beyond that window.

For iron deficiency, oral ferrous sulfate 325 mg (65 mg elemental iron) taken every other day optimizes absorption while minimizing gastrointestinal side effects. A 2017 randomized trial (N=217) in The Lancet showed that alternate-day dosing achieved comparable ferritin repletion to daily dosing at 14 weeks [18]. Ferritin should be rechecked at 8 to 12 weeks; the target is above 50 ng/mL.

For hypothyroidism, levothyroxine replacement titrated to a TSH of 0.5 to 2.5 mIU/L typically normalizes nail growth within two to three thyroid half-life cycles (roughly 8 to 12 weeks after reaching a stable dose) [14].

For chemotherapy-induced Beau's lines, no active intervention is needed beyond completing the oncology treatment plan. A small pilot study (N=32) investigated cryotherapy (freezing gloves worn during infusion) and found a 40% reduction in nail toxicity, including Beau's lines, in treated hands compared to untreated hands [19]. Discuss this option with your oncologist before your next cycle.

For post-infectious Beau's lines (after COVID-19, pneumonia, or other acute illness), the lines grow out without treatment as long as no secondary deficiency or ongoing inflammatory process is present. The lab panel above rules out lingering contributors.

When to See a Specialist

Most Beau's lines do not require a specialist visit. Your primary care clinician can order the labs, interpret the results, and initiate treatment for common deficiencies. Referral becomes appropriate in specific scenarios.

See a dermatologist if the nail changes are atypical (pigmented bands, nail plate destruction, or periungual swelling accompany the grooves), if the diagnosis is uncertain after the lab workup, or if lines recur despite correction of identified deficiencies. A dermatologist can perform a nail plate biopsy or nail matrix biopsy when malignancy (subungual melanoma) or inflammatory nail disease (lichen planus) enters the differential [10].

See a rheumatologist if Raynaud's phenomenon, joint swelling, or a positive ANA accompanies the Beau's lines. Systemic sclerosis and lupus can cause recurrent digital ischemia severe enough to produce repeated growth arrest.

See an endocrinologist if thyroid function remains abnormal despite initial treatment, if hemoglobin A1c is above 9% with evidence of microvascular complications, or if pituitary pathology is suspected (multiple hormone axes affected simultaneously).

See a hematologist-oncologist if the CBC reveals unexplained cytopenias, if serum protein electrophoresis shows a monoclonal spike, or if Beau's lines appeared in the absence of any identifiable cause in a patient with constitutional symptoms (weight loss, night sweats, fatigue).

Monitoring and Follow-Up

A single set of Beau's lines from an identifiable past event (a hospitalization, a bout of influenza) needs no formal monitoring. Photograph the nails at baseline and again at three months to confirm the groove is migrating distally. That migration confirms the matrix has resumed normal function.

Recurrent Beau's lines are a different clinical problem. If new grooves appear before old ones have grown out, the underlying insult is ongoing or a new one has occurred. Repeat the lab panel. Pay particular attention to zinc, ferritin, and TSH, as subclinical deficiencies can re-emerge if supplementation was stopped too early or if dietary intake remains inadequate.

For patients on chemotherapy, nail photographs before each cycle create a visual timeline that helps the oncology team gauge cumulative nail toxicity. The Common Terminology Criteria for Adverse Events (CTCAE v5.0) grades nail changes from 1 (cosmetic) to 3 (limiting self-care activities of daily living) [20]. Grade 2 or higher nail toxicity warrants a discussion about dose modification or cryotherapy.

Nail growth is slow but predictable. A fingernail Beau's line that is 6 mm from the free edge will take approximately two months to reach the tip and be trimmed away. Patience is the appropriate clinical posture once the cause has been addressed and labs have normalized. If a groove has not moved after three months, revisit the diagnosis.